| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 01/14/2010 | CA2729186A1 Fatty acid acetylated salicylates and their uses |
| 01/13/2010 | EP1575911B1 Biaromatic compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions |
| 01/13/2010 | EP1399414B1 Substituted tetracycline compounds for the treatment of malaria |
| 01/13/2010 | CN101627007A Aminoamides as orexin antagonists |
| 01/13/2010 | CN100580087C Conjugation of peptides |
| 01/12/2010 | US7645805 a core which is functionalized with three amino acid derived groups by means of an amide or urea linkage. It may be used to gelate or thicken numerous solvents |
| 01/12/2010 | US7645799 thromboembolic and/or inflammatory disorders; 4-Aminomethyl-cyclohexanecarboxylic acid (1-biphenyl-3-yl-2-phenyl-ethyl)-amide; selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; improved pharmacological properties, plasma kallikrein activity |
| 01/12/2010 | US7645797 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 01/07/2010 | US20100004326 Metabolites of selective androgen receptor modulators and methods of use thereof |
| 01/07/2010 | US20100004211 7-N-Substituted Phenyl Tetracycline Compounds |
| 01/07/2010 | US20100003216 HCV NS-3 Serine Protease Inhibitors |
| 01/05/2010 | US7642379 Aminoacetonitrile derivatives and their use for controlling parasites on warm-blooded animals |
| 01/05/2010 | US7642367 Diamino-functional chalcones |
| 01/05/2010 | US7641799 Method of separating isotopes |
| 01/05/2010 | CA2395601C Dibenzo (b,f) azepine intermediates |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 01/05/2010 | CA2271333C Poly-perfluoroalkyl substituted polyamines as grease proofing agents for paper and foam stabilizers in aqueous fire-fighting foams |
| 01/05/2010 | CA2184681C Process for preparing substituted n-ethylglycine derivatives |
| 12/31/2009 | US20090326059 Benzyloxy anilide derivatives useful as potassium channel modulators |
| 12/31/2009 | US20090325962 Tyrosine derivative |
| 12/31/2009 | US20090325940 Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof |
| 12/31/2009 | US20090325908 9-substituted minocycline compounds |
| 12/31/2009 | US20090324540 Compounds and compositions for delivering active agents |
| 12/30/2009 | WO2009157196A1 Amide compound |
| 12/30/2009 | EP1711481B1 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| 12/30/2009 | CN100574753C Medicinal salt with local narcosis and antiphlogosis activity and its preparation process |
| 12/29/2009 | US7638650 Fluoroalkyl surfactants |
| 12/29/2009 | US7638630 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors |
| 12/29/2009 | CA2477851C Small molecule entry inhibitors |
| 12/29/2009 | CA2204734C Process for the crystallization from water of (s)-n,n'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[(2-hydroxy-1-oxopropyl)amino]-2,4,6-triiodo-1,3-benzendicarboxamide |
| 12/24/2009 | US20090314639 Means and devices for electro-filtration of molecules |
| 12/23/2009 | WO2009155088A1 Use of zinc chelators to inhibit biofilm formation |
| 12/23/2009 | WO2009113828A3 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid |
| 12/23/2009 | EP2134703A1 Amide derivatives as calcium channel blockers |
| 12/23/2009 | EP1879564B1 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
| 12/23/2009 | CN101610991A Preparation of 3-amino-3-(cyclobutylmethyl)-2-(hydroxy)-propionamide hydrochloride |
| 12/23/2009 | CN100572356C Linking molecule for selective metallation of nucleic acid and its application |
| 12/22/2009 | CA2327465C Bipolar lipids capable of delivering polyanions to cells |
| 12/17/2009 | WO2009152474A2 Process for the preparation of (3s)-3-amino-n-cyclopropyl-2-hydroxyalkanamide derivatives |
| 12/17/2009 | WO2009151366A1 Chemical and method for chelating metal ions included in water and separating/recovering of formed chelate |
| 12/17/2009 | WO2009150248A1 Compounds which can be used for the treatment of cancers |
| 12/17/2009 | US20090312577 Process for Production of Beta-Amino-Alpha-Hydroxy Carbonxamide Derivative |
| 12/17/2009 | US20090312576 Process and intermediates for the preparation of 3-(amino)-3-cyclobutylmethyl-2-hydroxy-propionamide or salts thereof |
| 12/17/2009 | US20090312575 Process For Preparing A Benzoylbenzeneacetamide Derivative |
| 12/17/2009 | US20090312571 Process for the preparation of (3s)-3-amino-n-cyclopropyl-2-hydroxyalkanamide derivatives |
| 12/17/2009 | US20090312429 Administration of nepafenac or derivatives thereof for treating dermatological/keratinization disorders |
| 12/17/2009 | US20090312380 Novel compositions and methods |
| 12/17/2009 | US20090312365 Certain Chemical Entities, Compositions, and Methods |
| 12/17/2009 | US20090312363 Bifunctional histone deacetylase inhibitors |
| 12/17/2009 | CA2739217A1 Chemical and method for chelating metal ions included in water and separating/recovering of formed chelate |
| 12/17/2009 | CA2727296A1 Compounds which can be used for the treatment of cancers |
| 12/16/2009 | CN101605756A Water-soluble prodrugs of florfenicol and its analogs |
| 12/16/2009 | CN101602689A Synthesis technology of glutamine |
| 12/15/2009 | US7632850 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS |
| 12/10/2009 | WO2009149344A2 Solid states of aliskiren free base |
| 12/10/2009 | WO2009147165A1 Novel ep4 receptor agonist compounds |
| 12/10/2009 | WO2009146539A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers |
| 12/10/2009 | US20090306429 Preparation of a quaternary ammonium hydroxide and use thereof for the preparation of a quaternary ammonium salt |
| 12/10/2009 | US20090306404 Process for the Preparation of 2-azabicyclo[3.3.0]octane-3-carboxylic Acid Derivatives |
| 12/10/2009 | US20090306153 Synthesis and use of novel inhibitors and inactivators of protein arginine deiminases |
| 12/10/2009 | US20090306127 Certain Chemical Entities, Compositions and Methods |
| 12/10/2009 | US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 12/10/2009 | US20090306036 Methods of screening agents, conjugates or conjugate moieties for transport by a pept2 transporter |
| 12/10/2009 | US20090306022 7-substituted tetracycline compounds |
| 12/10/2009 | US20090305568 Connection Member and Harness Connection Body Using the Connection Member |
| 12/10/2009 | CA2724320A1 Solid states of aliskiren free base |
| 12/10/2009 | CA2722723A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers |
| 12/09/2009 | CN101600682A Process for making 3-substituted 2-amino-5-halobenzamides |
| 12/09/2009 | CN101597239A Method for synthesizing theanine |
| 12/09/2009 | CN100567296C Triazolopyridazines as inhibitors of protein kinases |
| 12/08/2009 | US7629358 For therapy of inflammatory, allergic and respiratory diseases |
| 12/08/2009 | US7629332 Antitumor agents such as 2-[(2-Bromoethyl)-2,4-dinitro-6-[[[2-(phosphonooxy)ethyl]amino]-carbonyl]anilino]ethyl methanesulfonate; killing hypoxic cells in a tumor |
| 12/03/2009 | WO2009146325A1 Polymorphic and amorphous forms of lacosamide and amorphous compositions |
| 12/03/2009 | WO2009145839A1 Polyamine compounds that bind tar rna of hiv and methods of treating viral disorders |
| 12/02/2009 | EP2128124A1 Novel hexatriene- -carbonyl compound |
| 12/02/2009 | EP2128123A1 Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof |
| 12/02/2009 | EP2125705A2 Crystalline minocycline base and processes for its preparation |
| 12/02/2009 | CN101594857A Crystalline forms of aliskiren hemifumarate |
| 12/02/2009 | CN101591264A Preparation method of crystal L-glutamine alpha-ketoglutarate |
| 12/01/2009 | US7625948 Ester that inhibits MTP in intestines as antilipemic agents for side effect reduction |
| 11/26/2009 | WO2009143423A1 Aliskiren monofumarate and processes for preparation thereof |
| 11/26/2009 | WO2009141091A1 Novel [f-18] -labelled l-glutamic acid- and l-glutamine derivatives (i), use thereof and method for their production |
| 11/26/2009 | WO2009141090A1 {f-19} -labeled l-glutamic acid and l-glutamine derivative (iii), use thereof and method for obtaining them |
| 11/26/2009 | WO2009140765A1 Selective caspase inhibitors and uses thereof |
| 11/26/2009 | WO2009106713A3 New class of cationic lipids for transporting active agents into cells |
| 11/26/2009 | WO2009080722A3 Carboxylic derivatives for use in the treatment of cancer |
| 11/26/2009 | US20090292024 Substituted propanamide derivative and pharmaceutical composition containing the same |
| 11/26/2009 | US20090291998 Eponemycin and epoxomicin analogs and uses thereof |
| 11/26/2009 | US20090291988 Reversible Inhibitors of Monoamine Oxidase A and B |
| 11/26/2009 | US20090291970 Substituted Aminoethers for the Treatment of Alzheimer's Disease |
| 11/26/2009 | US20090291945 Cysteine protease inhibitors |
| 11/26/2009 | US20090288768 Di-cinnamyl compounds and methods for use thereof |
| 11/26/2009 | CA2724897A1 Salts and polymorphs of a tetracycline compound |
| 11/26/2009 | CA2724785A1 Selective caspase inhibitors and uses thereof |
| 11/26/2009 | CA2724746A1 Aliskiren monofumarate and processes for preparation thereof |
| 11/26/2009 | CA2723596A1 Novel [f-18]-labelled l-glutamic acid and l-glutamine derivatives (i), their use and processes for their preparation |
| 11/26/2009 | CA2723594A1 {f-19}-labeled l-glutamic acid and l-glutamine derivative (iii), use thereof and method for obtaining them |
| 11/25/2009 | EP2123621A1 New [F-18]-marked L-glutamic acids and L-glutamic acid derivatives (1), application thereof and method for their manufacture |
| 11/25/2009 | EP2123620A1 {F-19}-labeled L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them |
| 11/25/2009 | EP2123251A1 Composition for external application to skin |